Glucagonoma syndrome: Survival 21 years with concurrent liver metastases

American Journal of the Medical Sciences

Volumn 334, Issue 3, 2007, Pages 225-227

  Dourakis, Spyros P ^a   Alexopoulou, Alexandra ^a,d   Georgousi, Kleoniki K ^a   Delladetsima, Johanna K ^b   Tolis, George ^c   Archimandritis, Athanasios J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

^c HIPPOKRATION HOSPITAL   (Greece)

^d NONE   (Greece)

Author keywords

Glucagonoma; Liver metastasis; Long term survival

Indexed keywords

AMISULPRIDE; GLICLAZIDE; PENTETREOTIDE IN 111; ZINC SULFATE;

ADULT; ANAMNESIS; ARTICLE; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; GLUCAGONOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LIVER METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RASH; STOMACH BIOPSY; SURVIVAL TIME; TUMOR CALCINOSIS; TUMOR GROWTH;

CALCINOSIS; FOLLOW-UP STUDIES; GLUCAGONOMA; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34548675811     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e318141ff0b     Document Type: Article

References (13)

1. Brentjens R, Saltz L. Islet cell tumors of the pancreas: the medical oncologist's perspective. Surg Clin North Am 2001;81:527-41.
2. Frankton S, Bloom SR. Gastrointestinal endocrine tumours. Glucagonomas. Baillieres Clin Gastroenterol 1996;10:697-705.
3. Schwartz RA. Glucagonoma and pseudoglucagonoma syndromes. Int J Dermatol 1997;36:81-9.
4. Chu QD, Al-kasspooles MF, Smith JL, et al. Is glucagonoma of the pancreas a curable disease? Int J Pancreatol 2001;29:155-62.
5. Wermers RA, Fatourechi V, Wynne AG, et al. The glucagonoma syndrome: clinical and pathologic features in 21 patients. Medicine (Baltimore) 1996;75:53-63.
6. Nightingale KJ, Davies MG, Kingsnorth AN. Glucagonoma syndrome: survival 24 years following diagnosis. Dig Surg 1999;16:68-71.
7. Chastain MA. The glucagonoma syndrome: a review of its features and discussion of new perspectives. Am J Med Sci 2001;321:306-20.
8. Stone MS, Adler M, Helm RN, et al. Self-assessment examination of the American Academy of Dermatology: necrolytic migratory erythema, erythema gyratum repens and calciphylaxis. J Am Acad Dermatol 1997;37(5 Pt 1):814-6.
9. Easson AM, Barron PT, Cripps C, et al. Calcification in colorectal hepatic metastases correlates with longer survival. J Surg Oncol 1996;63:221-5.
10. Lam KY, Lo CY. Pancreatic endocrine tumour: a 22-year clinico-pathological experience with morphological, immunohistochemical observation and a review of the literature. Eur J Surg Oncol 1997;23:36-42.
11. Breatnach ES, Han SY, Rahatzad MT, et al. CT evaluation of glucagonomas. J Comput Assist Tomogr 1985;9:25-9.
12. Tomassetti P, Migliori M, Corinaldesi R, et al. Treatment of gastropancreatic neuroendocrine tumours with octreotide LAR. Aliment Pharmacol Ther 2000;14:557-60.
13. Hellman P, Ladjevardi S, Skogseid B, et al. Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors. World J Surg 2002;26:1052-6.